SCHEMBL6710073

SCHEMBL6710073

O=C(Nc1ccc(Cl)cc1-c1noc(=O)[nH]1)c1cc2cccc(NC(=O)C3CCOC3)c2[nH]1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIK1 P39086 1/20 0.39
PLCG2 P16885 1/20 0.39
SERPINE1 P05121 1/20 0.35
PLA2G7 Q13093 1/20 0.35
POLB P06746 2/20 0.34
MDM2 Q00987 1/20 0.34
PYGL P06737 1/20 0.33
PTK2B Q14289 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC2 Q92769 1/20 0.33
MAPK10 P53779 1/20 0.33
LMNA P02545 1/20 0.33
TP53 P04637 1/20 0.33
NHERF1 O14745 2/20 0.33
PIP5K1C O60331 1/20 0.33
PIK3CA P42336 1/20 0.33
STK33 Q9BYT3 1/20 0.33
CMKLR1 Q99788 1/20 0.33
P2RX3 P56373 1/20 0.33
MAPK14 Q16539 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6707685 0.92 GRIK1 (0.42) GRIK1PLCG2PLA2G7POLBPTK2B
SCHEMBL6714070 0.91 GRIK1 (0.37) GRIK1POLBHDAC1HDAC2MAPK10
SCHEMBL6711491 0.91 GRIK1 (0.41) GRIK1PLCG2PLA2G7POLBPTK2B
SCHEMBL6708935 0.91 GRIK1 (0.41) GRIK1PLCG2PLA2G7MDM2PYGL
SCHEMBL6708773 0.90 GRIK1 (0.41) GRIK1PLCG2SERPINE1PLA2G7MDM2
SCHEMBL6708822 0.89 RORC (0.34) PLA2G7HDAC1HDAC2MAPK10PIP5K1C
SCHEMBL6707660 0.86 PLCG2 (0.37) PLCG2SERPINE1POLBPYGLPTK2B
SCHEMBL6707970 0.85 GRIK1 (0.39) GRIK1PLCG2PLA2G7POLBPYGL
SCHEMBL6707972 0.85 GRIK1 (0.39) GRIK1PLCG2PLA2G7POLBPYGL
SCHEMBL6707967 0.85 GRIK1 (0.39) GRIK1PLCG2PLA2G7POLBPYGL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed
WO-2004018461-A2 ANTIBACTERIAL BENZOIC ACID DERIVATIVES PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 GRIK1 3885/4885PLCG2 4289/4885SERPINE1 2108/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.